#USA #Atlanta #Eye Care #Nordic Pharma #LACRIFILL

Nordic Pharma Presents LACRIFILL® at SECO 2025

Nordic Pharma, Inc. has recently announced an important presentation regarding its innovative LACRIFILL® Canalicular Gel at the upcoming SECO 2025 conference. Scheduled from February 26 to March 2 in Atlanta, Georgia, this event is considered one of the leading educational meetings for optometry worldwide.

Mile Brujic, OD, FAAO from Premier Vision Group, will present the poster detailing a series of cases involving patients with refractory dry eye disease. The LACRIFILL Canalicular Gel is an advanced hyaluronic acid gel available in a single-use, pre-filled syringe that is administered through the tear duct using a cannula. This presentation promises to share valuable insights from three patients who had previously utilized dissolvable canalicular plugs for six months, demonstrating significant improvements in their symptoms post-treatment with LACRIFILL.

During the presentation, Dr. Brujic remarked, "LACRIFILL Canalicular Gel has proven to be something special in my practice. The series of cases covers three patients among many who showed significant corneal improvement and comfort when treated with LACRIFILL Canalicular Gel. I have also increased the number of occlusions I perform in my practice with this gel."

SECO International's annual conference is an unmatched opportunity for learning, featuring groundbreaking exhibits and innovative networking solutions. Phil Gioia, the President of the U.S. team, expressed enthusiasm about the positive effects of LACRIFILL Canalicular Gel, stating, "The power of optometrists managing LACRIFILL as an interventional treatment for dry eye and achieving such favorable results is something we continue to be excited about. We have been collaborating with eye care professionals since the launch of LACRIFILL Canalicular Gel last year and are committed to supporting the network of optometrists in their vital role in treating dry eye."

Presentation Details

Title: Novel Canalicular Gel for Lacrimal Occlusion Case Series
Presenter: Mile Brujic, OD, FAAO
Date and Time: February 28, 9:45 AM – 11:45 AM
Location: Georgia World Congress Center, Hall A-1 and A-2, Building A, Level 1, Optometry's Marketplace™

Following the SECO 2025 conference, posters will also be published online at SECO University, providing accessibility to a wider audience.

For more information on LACRIFILL Canalicular Gel and its impact on treating dry eye conditions, visit lacrifill.com.

About Nordic Group B.V.

Nordic Group B.V. is a privately-owned, medium-sized international pharmaceutical company focusing on the development and commercialization of specialized products. It has enhanced its portfolio through targeted acquisitions aimed at building a strong foundation in eye care, rheumatology, and women's health. Having established deep roots across Europe, Nordic Group has recently expanded globally with a surge in acquisitions.

About Nordic Pharma, Inc.

As a subsidiary of Nordic Group B.V., Nordic Pharma, Inc. collaborates with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotech-derived drugs, sterile manufacturing, and cutting-edge technologies to market.

Forward-Looking Statements

This press release includes forward-looking statements regarding Nordic Group/Nordic Pharma's business developments and strategic initiatives. As these statements reflect current opinions and beliefs regarding future events, they involve risks and uncertainties that could cause actual developments and outcomes to differ materially from expectations. Factors include market conditions, regulatory trends, changes in the financial circumstances of third parties dealing with Nordic Group/Nordic Pharma, among others. Nordic Group/Nordic Pharma assumes no obligation to publicly update any forward-looking statements as a result of new information, future developments, or otherwise.

Contacts

Nordic Pharma, Inc.
Kate Popova
Project and Contracts Manager
Tel. 610-285-1699
Email: [email protected]
Gail Feerrar
Director of Sales and Marketing
Tel. 610-285-7152
Email: [email protected]